Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronicles in drug discovery.

Shelley L Davies1, Elisa Ferrer, Maria Angels Moral

  • 1Prous Science, Barcelona, Spain.

Drug News & Perspectives
|August 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a Web Platform to Facilitate the Implementation and Evaluation of Health Promoting Schools: Protocol for a Double Diamond Design Approach.

JMIR research protocols·2024
Same author

Sustaining Meaningful Patient Engagement Across the Lifecycle of Medicines: A Roadmap for Action.

Therapeutic innovation & regulatory science·2021
Same author

Evaluation of patient engagement in medicine development: A multi-stakeholder framework with metrics.

Health expectations : an international journal of public participation in health care and health policy·2021
Same author

Understanding multi-stakeholder needs, preferences and expectations to define effective practices and processes of patient engagement in medicine development: A mixed-methods study.

Health expectations : an international journal of public participation in health care and health policy·2021
Same author

Evaluating the "return on patient engagement initiatives" in medicines research and development: A literature review.

Health expectations : an international journal of public participation in health care and health policy·2019
Same author

Pharmaceutical trademarks: navigating through the FDA's pilot program.

Drug news & perspectives·2010

New drug discovery strategies aim to prevent chemotherapy side effects like oral mucositis and address antibiotic limitations. Research also explores trachoma treatments and nicotine receptor modulators for smoking cessation.

Area of Science:

  • Drug Discovery and Development
  • Oncology
  • Ophthalmology
  • Pharmacology

Background:

  • Oral mucositis is a debilitating chemotherapy side effect impacting treatment adherence.
  • Gentamicin, an effective antibiotic, causes acute renal failure, limiting its use.
  • Trachoma remains a leading cause of preventable blindness globally.

Purpose of the Study:

  • To review novel therapeutic strategies for preventing chemotherapy-induced oral mucositis.
  • To explore new antibiotic approaches for trachoma and vaccine development.
  • To discuss allosteric-potentiating ligands for smoking cessation.

Main Methods:

  • Focus on mechanism-based therapies targeting DNA damage and inflammatory cascades.

Related Experiment Videos

  • Investigating targets like kallikreins, peroxynitrite, and aminoglycoside accumulation.
  • Examining allosteric modulation of nicotinic acetylcholine receptors.

    • Main Results:

    • Emerging therapies aim to repair cellular damage and alleviate pain associated with oral mucositis.
    • Potential targets identified for overcoming gentamicin's nephrotoxicity.
    • New antibiotic strategies and vaccine candidates for trachoma are under investigation.

    Conclusions:

    • Advances in drug discovery offer promising avenues for managing chemotherapy side effects.
    • Novel approaches are being developed to combat infectious diseases like trachoma.
    • Nicotinic acetylcholine receptor modulation presents a potential strategy for smoking cessation.